BrightSpring Health Services Inc. BTSG 深 滬
等待開盤 10-21 09:30:00 美东时间
30.47
+0.740
+2.49%
華盛通- 最 高30.595
- 今 開29.85
- 成交量 299.13万股
- 最 低 29.60
- 昨 收 29.73
- 總市值 53.93亿
- 52周最高 31.95
- 市盈率 靜 --
- 換手率 1.69%
- 52周最低 14.73
- 委 比 90.75%
- 總股本 1.77亿
- 歷史最高 31.95
- 量 比 0.42
- 振 幅 3.35%
- 歷史最低 7.85
- 每 手 1
- 風險率 3.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BrightSpring announces secondary offering
BrightSpring Health Services (NASDAQ:BTSG) said certain shareholders, including an affiliate of KKR and company executives, plan to sell 15 million shares of common stock in a secondary offering. The ...
今天 04:51
BrightSpring Health Sees Prelim Q3 Adj EPS $0.30 vs $0.27 Est; Sees Sales $3.334B vs $3.167B Est
BrightSpring Health (NASDAQ:BTSG) is looking for Prelim Q3 Adj EPS of $0.30 vs $0.27 analyst estimate. sees sales of $3.334 billion vs $3.167 billion analyst estimate.
今天 04:30
BrightSpring Health reports preliminary third quarter revenue, increases FY25 guidance
BrightSpring Health Services, Inc. (NASDAQ:BTSG) on Monday reported preliminary third-quarter 2025 revenue of $3.33 billion, up 28% from $2.60 billion a year earlier. Adjusted EBITDA rose 37% to $160 ...
今天 04:23
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
Demystifying BrightSpring Health: Insights From 5 Analyst Reviews
During the last three months, 5 analysts shared their evaluations of BrightSpri...
10-17 22:01
Is BrightSpring Health Services Inc Gaining or Losing Market Support?
BrightSpring Health Services Inc's (NYSE:BTSG) short interest as a percent of f...
10-16 03:01
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $32
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $25 to $32.
10-14 23:30
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
